RxDoctor Payments Data

Monika Malysa-Houben

Nurse Practitioner · Southfield, MINPI 1184187528

Payments from drug & device makers

$4,955in general payments, 2019–2025

Across 48 payments — averaging $103.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$606
  • AstraZeneca$465
  • Novo Nordisk$372
  • Medtronic$279
  • Otsuka America Pharmaceutical, Inc.$265
  • Acadia Pharmaceuticals Inc$192
  • plus $3K from 24 others

What the payments were for

  • Food & beverage$4,955100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,955 in reported general payments places this provider in the 95th percentile of 3,351 nurse practitioner providers in Michigan.

See all nurse practitioner providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban49$28,659
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$20,719
Spiriva RespimatTiotropium Bromide32$17,747
JardianceEmpagliflozin26$14,416
Atorvastatin Calcium252$14,050
EntrestoSacubitril/Valsartan13$8,384
Sevelamer Carbonate23$8,223
Quetiapine Fumarate94$7,982
FarxigaDapagliflozin Propanediol13$7,407
Pregabalin34$6,062
Duloxetine Hcl72$5,942
Donepezil Hcl50$5,398
Memantine Hcl61$5,257
Lacosamide14$4,509
Pantoprazole Sodium77$4,504

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$123$28,65949 claims
AstraZenecaFarxiga$465$7,40713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,351 nurse practitioner providers in Michigan.

Other nurse practitioner in Southfield

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →